drugset

drugset / Trial / NCT01066156

Post-Traumatic Stress Disorder (PTSD) and Seroquel

NCT01066156 ↗

Completed 34 enrolled Cambridge Health Alliance

NaSingle-groupOpen-labelTreatment

Summary

This 8 weeks study will investigate therapeutic responses to Seroquel pharmacotherapy in PTSD.

Timeline

Start: 2010-02
Primary completion: 2015-03
Completion: 2015-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Quetiapine	Small molecule	25 mg	—

Indications